These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5617888)

  • 1. [On the fibrinolytic effect of the combination of kallikrein with meso-inositol hexanicotinate].
    Zedda S
    Clin Ter; 1967 Sep; 42(6):509-24. PubMed ID: 5617888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ocular changes experimentally induced in guinea pigs treated with an association of kallikrein and meso-inositol hexanicotinate].
    Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):544-54. PubMed ID: 5761261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].
    Paltauf F; Pristautz H; el Eisch IA
    Acta Med Austriaca; 1977; 4(3):120-4. PubMed ID: 930544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
    Sommer H
    Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 7. [PHARMACOLOGICAL EXPERIMENTS WITH A COMBINATION OF KALLIKREIN AND MESO-INOSITOL HEXANICOTINATE].
    PAGLIANI P; GIOSEFFI G
    Boll Chim Farm; 1964 Jul; 103():504-21. PubMed ID: 14200698
    [No Abstract]   [Full Text] [Related]  

  • 8. The cutaneous reactions to kallikrein, prostaglandin and thurfyl nicotinate in chronic urticaria and the effect of polyphloretin phosphate.
    Thune P; Ryan TJ; Powell SM; Ellis JR
    Acta Derm Venereol; 1976; 56(3):217-21. PubMed ID: 59506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
    Linari G
    Arzneimittelforschung; 1972 Aug; 22(8):1419-21. PubMed ID: 4678404
    [No Abstract]   [Full Text] [Related]  

  • 12. [Critical review on vasodilators].
    Goto F; Akiyama M
    Jibiinkoka; 1969 Oct; 40(10):785-96. PubMed ID: 4236877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activation of fibrinolysis induced by D-glucitol-hexanicotinate].
    Novo S; Avellone G; Pinto A; Fazio M
    Farmaco Prat; 1980 Mar; 35(3):155-60. PubMed ID: 7439356
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of meso-inositol hexanicotinate on arteriosclerosis].
    Kimura N; Nishimoto S; Mori I; Mizuguchi N; Yoshinaga M
    Nihon Rinsho; 1966 Mar; 24(3):576-82. PubMed ID: 6007313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
    Kiseleva LN; Romanenko GK
    Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
    [No Abstract]   [Full Text] [Related]  

  • 18. [FIRST EXPERIENCES ON THE THERAPEUTIC ACTIVITY OF M-INOSITOL HEXANICOTINATE AND KALLIKREIN IN PERIPHERAL VASCULAR DISEASES AND IN CORONARY DISEASE].
    LIOTTA S
    Policlinico Prat; 1964 Dec; 71():1874-84. PubMed ID: 14253722
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits.
    De Nicola P; Gibelli A; Turazza G
    Thromb Diath Haemorrh; 1966 Jan; 15(1):231-7. PubMed ID: 5919803
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis.
    Robertson BR
    Acta Chir Scand; 1971; 137(7):643-8. PubMed ID: 5149150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.